Handelsbanken Fonder AB - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$201
-56.1%
9,7440.0%0.00%
-50.0%
Q2 2023$458
+12.0%
9,7440.0%0.00%0.0%
Q1 2023$409
+9.9%
9,7440.0%0.00%0.0%
Q4 2022$372
-99.9%
9,7440.0%0.00%
-33.3%
Q3 2022$382,000
+21.3%
9,7440.0%0.00%
+50.0%
Q2 2022$315,000
-2.5%
9,7440.0%0.00%0.0%
Q1 2022$323,000
-22.2%
9,7440.0%0.00%0.0%
Q4 2021$415,000
-3.9%
9,7440.0%0.00%0.0%
Q3 2021$432,000
-22.0%
9,7440.0%0.00%
-33.3%
Q2 2021$554,000
-25.5%
9,744
-2.0%
0.00%
-25.0%
Q1 2021$744,000
-13.5%
9,9440.0%0.00%
-20.0%
Q4 2020$860,000
+72.7%
9,944
+22.1%
0.01%
+25.0%
Q3 2020$498,000
-26.5%
8,144
-50.0%
0.00%
+33.3%
Q2 2020$678,000
-39.2%
16,288
+16.3%
0.00%
-89.3%
Q2 2017$1,115,000
-12.8%
14,000
-22.2%
0.03%
-22.2%
Q1 2017$1,279,00018,0000.04%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,966,688$120,204,00010.81%
Integral Health Asset Management, LLC 230,000$14,058,0004.30%
Asymmetry Capital Management, L.P. 102,462$6,262,0004.02%
ACUTA CAPITAL PARTNERS, LLC 225,000$13,752,0003.74%
DAFNA Capital Management LLC 158,306$9,676,0003.14%
Bain Capital Life Sciences Investors, LLC 499,100$30,505,0002.84%
Boxer Capital, LLC 1,094,000$66,865,0002.31%
Palo Alto Investors LP 590,200$36,073,0001.98%
Logos Global Management LP 250,000$15,280,0001.96%
Bellevue Group AG 1,579,504$96,539,0001.33%
View complete list of SAGE THERAPEUTICS INC shareholders